# Neurocrine Biosciences, Inc. (NBIX)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/NBIX/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 1.77B | $ 342.30M | $ 265.30M | $ 401.80M | $ 3.69B |
| 2025 | $ 2.93B | $ 490.04M | $ 766.60M | $ 415.30M | $ 3.25B |
| 2024 | $ 2.48B | $ 358.73M | $ 585.66M | $ 455.10M | $ 2.59B |
| 2023 | $ 2.04B | $ 269.99M | $ 390.98M | $ 428.40M | $ 2.23B |
| 2022 | $ 1.66B | $ 172.59M | $ 360.71M | $ 262.90M | $ 1.71B |
| 2021 | $ 1.35B | $ 106.50M | $ 277.07M | $ 440.40M | $ 1.37B |
| 2020 | $ 1.33B | $ 518.87M | $ 270.07M | $ 412.30M | $ 1.13B |
| 2019 | $ 1.02B | $ 47.77M | $ 177.27M | $ 495.50M | $ 636.90M |
| 2018 | $ 595.95M | $ 27.88M | $ 101.10M | $ 388.50M | $ 480.77M |
| 2017 | $ 217.73M | $ -192.02M | $ -136.43M | $ 369.62M | $ 372.14M |
| 2016 | $ 20.64M | $ -194.12M | $ -151.74M | $ 0 | $ 314.88M |
| 2015 | $ 27.76M | $ -124.86M | $ -56.06M | $ 0 | $ 424.45M |
| 2014 | $ 0 | $ -85.55M | $ -68.89M | $ 0 | $ 208.70M |
| 2013 | $ 4.15M | $ -65.55M | $ -42.88M | $ 0 | $ 120.41M |
| 2012 | $ 76.72M | $ 7.25M | $ -52.36M | $ 0 | $ 154.37M |
| 2011 | $ 113.73M | $ 55.20M | $ -2.10M | $ 0 | $ 60.08M |
| 2010 | $ 50.73M | $ -12.06M | $ 55.80M | $ 0 | $ 19.35M |
| 2009 | $ 4.47M | $ -77.28M | $ -80.45M | $ 11.53M | $ 3.95M |
| 2008 | $ 6.02M | $ -134.17M | $ -114.31M | $ 15.40M | $ 36.77M |
| 2007 | $ 1.85M | $ -313.88M | $ -90.79M | N/A | $ 118.70M |
| 2006 | $ 59.41M | $ -162.32M | $ -64.02M | $ 53.64M | $ 314.72M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.11 |
| Liabilities / Eq | 0.45 |
| Current Ratio | 1.87 |

## Debt coverage

| Indicator | Value |
| --- | --- |
| Gross Debt / Earnings | 1.98 |
| Gross Debt / FCF | 1.35 |

## Other views

- [Metrics](https://sponda.capital/en/NBIX.md)
- [Charts](https://sponda.capital/en/NBIX/charts.md)
- [Compare](https://sponda.capital/en/NBIX/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-30.